Scott A. Harding

ORCID: 0000-0003-4282-4107
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Peripheral Artery Disease Management
  • Cardiac Arrhythmias and Treatments
  • Vascular Procedures and Complications
  • Cardiac, Anesthesia and Surgical Outcomes
  • Lipoproteins and Cardiovascular Health
  • Cardiac Fibrosis and Remodeling
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Atherosclerosis and Cardiovascular Diseases
  • Atrial Fibrillation Management and Outcomes
  • Central Venous Catheters and Hemodialysis
  • Cardiac Valve Diseases and Treatments
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cardiovascular Disease and Adiposity
  • Immune Response and Inflammation
  • Cerebrovascular and Carotid Artery Diseases
  • Inflammatory Biomarkers in Disease Prognosis
  • Cardiac Structural Anomalies and Repair

Wellington Hospital
2016-2025

Victoria University of Wellington
2012-2024

Capital and Coast District Health Board
2011-2022

University of Otago
2014-2022

Harding University Main Campus
2021

University of Lisbon
2021

University of Edinburgh
2006-2016

Royal Perth Hospital
2014

British Heart Foundation
2013

Edinburgh Royal Infirmary
2001-2010

Noncardiac surgery performed after coronary stent implantation is associated with an increased risk of thrombosis, myocardial infarction, and death. The influence type period still have to be defined.We linked the Scottish Coronary Revascularisation Register hospital admission data undertake a Scotland-wide retrospective cohort study examining cardiac outcomes in all patients who received drug-eluting or bare-metal stents between April 2003 March 2007 subsequently underwent noncardiac...

10.1161/circinterventions.109.934703 article EN Circulation Cardiovascular Interventions 2010-05-05

Intravenous ribavirin was provided non-selectively for investigational open-label use among persons with suspected hantavirus pulmonary syndrome (HPS) in the United States between 4 June 1993 and 1 September 1994. Therapy initiated prior to laboratory confirmation of infection because most deaths from HPS occur within 48 h hospitalization. Thirty patients confirmed HPS, 105 without 5 adequate diagnostic testing were enrolled. This observational study arguably provides complete information...

10.1177/135965359900400404 article EN Antiviral Therapy 1999-05-01

The inflammatory cytokine, tumour necrosis factor α (TNF-α), exerts deleterious cardiovascular effects. We wished to determine the effects of TNF-α antagonism on endothelial function and platelet activation in patients with acute myocardial infarction.A double-blind, parallel group, randomised controlled trial performed a tertiary referral cardiac centre. 26 presenting infarction receive an intravenous infusion etanercept (10 mg) or saline placebo.Leucocyte count, plasma cytokine...

10.1136/heartjnl-2013-303648 article EN cc-by-nc Heart 2013-04-10

Multiple sclerosis (MS) is an immune‐driven, demyelinating disease of the central nervous system (CNS). Although many types immune cells are involved in progression, activated monocytes believed to be one first arrive brain and initiate inflammation. However, little known about how two main monocyte subsets, CD14 ++ CD16 − + , MS. To understand phenotype responses these subsets altered during MS, total purified from healthy subjects ( n =29) MS patients =20) were characterized ex vivo...

10.1038/icb.2014.15 article EN Immunology and Cell Biology 2014-03-18

Background— Smoking is a potent cardiovascular risk factor and associated with proinflammatory prothrombotic responses. The CD40/CD40 ligand (CD40L) dyad platelet-monocyte aggregation mediate range of processes thought to be important in atherothrombosis. We investigated whether expression the CD40/CD40L are altered cigarette smokers. Methods Results— C-reactive protein (CRP), soluble (s) CD40L, surface CD40L on platelets T cells CD40 monocytes aggregates were compared 25 smokers age-...

10.1161/01.cir.0000127128.52679.e4 article EN Circulation 2004-04-13

10.1093/bja/78.2.175 article EN publisher-specific-oa British Journal of Anaesthesia 1997-02-01

Activation of both platelets and neutrophils can contribute to the risk major adverse cardiovascular events (MACE) following acute myocardial infarction (AMI). Neutrophil extracellular traps (NETs) are an important product platelet-neutrophil axis exaggerate vascular damage in disease. Additionally, activated drive NETosis directly linked thromboembolic risk. Investigating combined effect biomarkers for platelet activation represents a novel approach prediction post-AMI. Here, we examined...

10.1055/s-0041-1728763 article EN Thrombosis and Haemostasis 2021-05-13
Eugene B. Wu Arun Kalyanasundaram Emmanouil S Brilakis Kambis Mashayekhi Etsuo Tsuchikane and 95 more Nidal Abi Rafeh Pierfrancesco Agostoni Khaldoon Alaswad Mario Araya Alexandre Avran Mohamed Ayoub Lorenzo Azzalini А. М. Бабунашвили Baktash Bayani Michael Behnes Ravinay Bhindi Nicolas Boudou Marouane Boukhris Nenad Božinović Leszek Bryniarski Alexander Bufe Christopher E. Buller M. Nicholas Burke Heinz Joachim Buettner Pedro Cardoso Mauro Carlino Chi Kin Chan Jiyan Chen Evald Høj Christiansen Antonio Colombo Kevin Croce Félix Damas de los Santos Tony De Martini Joseph Dens Carlo Di Mario Darshan Doshi Kefei Dou Mohaned Egred Basem Elbarouni Ahmed ElGuindy Javier Escaned Sergey Furkalo Andrea Gagnor Alfredo R. Galassi Roberto Garbo Gabriele Gasparini Junbo Ge Lei Ge Pravin K. Goel Ömer Göktekín Nieves Gonzalo Şevket Görgülü Luca Grancini Allison B. Hall Colm G. Hanratty Stefan Harb Scott A. Harding Raja Hatem Farrel Hellig José P.S. Henriques David Hildick‐Smith Jonathan Hill Angela Hoye Wissam Jaber Farouc A. Jaffer Yangsoo Jang Risto Jussila Artis Kalniņš Sanjog Kalra David E. Kandzari Hsien‐Li Kao Dimitri Karmpaliotis Hussien Heshmat Kassem Kathleen E. Kearney Jimmy Kerrigan Jaikirshan Khatri Dmitri Khelimskii Ajay J. Kirtane Paul Knaapen Ran Kornowski Oleg Krestyaninov Vinay Kumar Prathap Kumar Pablo Lamelas Seung‐Whan Lee Thierry Lefévre Gregor Leibundgut Raymond Leung Sum-Kin Leung Yu Li Yue Li Soo-Teik Lim S. Lo William Lombardi Anbukarasi Maran Margaret McEntegart Jeffrey W. Moses Muhammad Munawar Wataru Nagamatsu Andrés Navarro

10.1016/j.hlc.2023.11.030 article EN Heart Lung and Circulation 2024-06-04

Abstract Contrast‐induced nephropathy (CIN) is a common complication of cardiac catheterization, reported to result in 15% incidence acute renal failure. Convincing evidence supports the prophylactic use prehydration and low volumes contrast medium. Recently, antioxidant acetylcysteine has been shown have potential preventive role. The aim this study was examine hypothesis that prevents CIN. Patients undergoing catheterization with serum creatinine ≥ 1.5 mg/dl were prospectively randomized...

10.1002/ccd.10684 article EN Catheterization and Cardiovascular Interventions 2003-11-10

Platelet-monocyte aggregates are increasingly being used to quantify platelet activation. The variables that influence platelet-monocyte have not been well defined. We sought determine the effect of blood collection, handling and processing techniques on detected levels using a flow cytometric assay. Whole was labelled with anti-CD14-PE anti-CD42a-FITC. Thereafter, samples were fixed red cells lysed. Analysis performed cytometer initially triggering light scatter then FL-2 identify CD14-PE...

10.1160/th06-11-0654 article EN Thrombosis and Haemostasis 2007-01-01

The use of a retrograde approach and algorithm-driven CTO (chronic total occlusion) percutaneous coronary intervention (PCI) has become widespread, many registries have reported good results. This study established new algorithm applied it to current practice collected registry document the It compared outcomes versus antegrade in contemporary multicentre registry.Between 1 January 2016 31 December 2016, consecutive patients who underwent PCI performed by eight high-volume operators were...

10.1016/j.hlc.2019.05.188 article EN cc-by-nc-nd Heart Lung and Circulation 2019-07-02

<h3>Objective</h3> The effects of ω-3 fatty acids on endothelial function, fibrinolysis and platelet function are uncertain. We investigated the acid supplementation vasomotor endogenous fibrinolysis, monocyte activation in healthy cigarette smokers; a group at increased risk myocardial infarction. <h3>Design, setting, participants</h3> Twenty smokers were recruited into randomised, double-blind, placebo-controlled, crossover trial supplementation. <h3>Intervention</h3> supplements (2 g/day)...

10.1136/heartjnl-2012-302924 article EN Heart 2012-11-26

Factors affecting the Multiplate® assay's analytical precision have not been well defined. We investigated effect of methodological factors on measurement ADP-induced platelet aggregation using assay. was analysed in whole blood tested reproducibility measurement, different anticoagulants (hirudin, citrate and heparin) time delay (15, 30, 45, 60, 120 180 minutes) between sampling analysis patients. The use a manual calibrated pipette with analyser also tested. mean coefficient variation (CV)...

10.3109/09537104.2012.694086 article EN Platelets 2012-06-11
Coming Soon ...